Notation to File

CASTLE BIOSCIENCES

Castle Biosciences Incorporated

Notation to File

NOTE TO THE FILE


SERIAL NUMBER:            88471422

DATE:                                10/16/2019

NAME:                               aburdecki

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
    X   phone                               Left message with
    X   email                               Attorney/Applicant

     Requested Law Library search       X   Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

 X   OTHER: Removed unrelated prior registrations

From: James Petruzzi <jdpetruzzi@gmail.com>
Sent: Wednesday, October 16, 2019 5:15 PM
To: Burdecki, Anna <Anna.Burdecki@USPTO.GOV>
Subject: Re: 88471422 CASTLE BIOSCIENCES - Proposed Examiner's Amendment

 

Annie,

 

Thanks for following up.  That amendment looks fine.  Please proceed with an Examiner’s Amendment.

 

Jim

_______________________________

 

James D. Petruzzi

The Petruzzi Law Firm

4900 Woodway Dr. Suite 745 |Houston, Texas 77056

Tel: (713) 840-9993 | Fax: (713) 877-9100       

Jim@Petruzzi.com | vCard

 



On Oct 16, 2019, at 4:13 PM, Burdecki, Anna <Anna.Burdecki@USPTO.GOV> wrote:

 

Hi Jim, 

 

Nice talking to you just now.  As discussed, I would suggest amending the ID as follows, if correct:

 

               Class 44 Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic cancers, namely genetic expression profiling and gene sequencing; Providing medical information to dermatologists, surgeons, and oncologists regarding the risk of metastasis for diagnostic support purposes thereby effecting changes in patient treatment plans

 

If you’d like me to make the amendment via Examiner’s Amendment, please let me know.  If you have any questions, feel free to give me a call back.


Sincerely, 

 

Annie

 

/Annie Burdecki, Esq./

Trademark Examining Attorney

Law Office 108

United States Patent & Trademark Office

Phone: 571-270-1941

anna.burdecki@uspto.gov

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed